A decision-analytic Markov model , based on MANTRA-PAF ( Medical Antiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation ) study data , was developed to study long-term effects and costs of RFA compared with AADs as first-line treatment .